HTG Molecular, Sanofi Ink Companion Dx Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – HTG Molecular Diagnostics today said that it will collaborate with Sanofi US on identifying biomarkers that could become a molecular companion diagnostic test.

The potential test would identify patients most likely to respond to an investigational drug being developed by Sanofi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.